[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Vagus Nerve Stimulators (VNS) - Medical Devices Pipeline Assessment, 2019

December 2019 | 121 pages | ID: V6CAD36ECE93EN
GlobalData

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Vagus Nerve Stimulators (VNS) - Medical Devices Pipeline Assessment, 2019

SUMMARY

GlobalData's Medical Devices sector report, “Vagus Nerve Stimulators (VNS) - Medical Devices Pipeline Assessment, 2019' provides an overview of Vagus Nerve Stimulators (VNS) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Vagus Nerve Stimulators (VNS) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

SCOPE
  • Extensive coverage of the Vagus Nerve Stimulators (VNS) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Vagus Nerve Stimulators (VNS) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
REASONS TO BUY

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Vagus Nerve Stimulators (VNS) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
1.1 List of Tables
1.2 List of Figures

2 INTRODUCTION

2.1 Vagus Nerve Stimulators (VNS) Overview

3 PRODUCTS UNDER DEVELOPMENT

3.1 Vagus Nerve Stimulators (VNS) - Pipeline Products by Stage of Development
3.2 Vagus Nerve Stimulators (VNS) - Pipeline Products by Territory
3.3 Vagus Nerve Stimulators (VNS) - Pipeline Products by Regulatory Path
3.4 Vagus Nerve Stimulators (VNS) - Pipeline Products by Estimated Approval Date
3.5 Vagus Nerve Stimulators (VNS) - Ongoing Clinical Trials

4 VAGUS NERVE STIMULATORS (VNS) - PIPELINE PRODUCTS UNDER DEVELOPMENT BY COMPANIES

4.1 Vagus Nerve Stimulators (VNS) Companies - Pipeline Products by Stage of Development
4.2 Vagus Nerve Stimulators (VNS) - Pipeline Products by Stage of Development

5 VAGUS NERVE STIMULATORS (VNS) COMPANIES AND PRODUCT OVERVIEW

5.1 Aucta Technologies Inc Company Overview
  5.1.1 Aucta Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Boston Scientific Corp Company Overview
  5.2.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.3 Cala Health Inc Company Overview
  5.3.1 Cala Health Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 CerboMed GmbH Company Overview
  5.4.1 CerboMed GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.5 Cyberonics Inc Company Overview
  5.5.1 Cyberonics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 DuoCure Ltd. Company Overview
  5.6.1 DuoCure Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.7 ElectroCore Inc Company Overview
  5.7.1 ElectroCore Inc Pipeline Products & Ongoing Clinical Trials Overview
5.8 LivaNova PLC Company Overview
  5.8.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
5.9 Medical University of South Carolina Company Overview
  5.9.1 Medical University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview
5.10 MicroTransponder Inc Company Overview
  5.10.1 MicroTransponder Inc Pipeline Products & Ongoing Clinical Trials Overview
5.11 Nexeon MedSystems Inc Company Overview
  5.11.1 Nexeon MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 Otto Bock HealthCare GmbH Company Overview
  5.12.1 Otto Bock HealthCare GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.13 Parasym Ltd Company Overview
  5.13.1 Parasym Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.14 Pulsus Medical LLC (Inactive) Company Overview
  5.14.1 Pulsus Medical LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.15 Purdue University Company Overview
  5.15.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview
5.16 Setpoint Medical Inc Company Overview
  5.16.1 Setpoint Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.17 Synergia Medical Company Overview
  5.17.1 Synergia Medical Pipeline Products & Ongoing Clinical Trials Overview
5.18 SzeleSTIM GmbH Company Overview
  5.18.1 SzeleSTIM GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.19 The Feinstein Institute for Medical Research Company Overview
  5.19.1 The Feinstein Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview
5.20 Trifectas Medical Corp. Company Overview
  5.20.1 Trifectas Medical Corp. Pipeline Products & Ongoing Clinical Trials Overview
5.21 University of Pittsburgh Company Overview
  5.21.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
5.22 University of Wisconsin Madison Company Overview
  5.22.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview

6 VAGUS NERVE STIMULATORS (VNS)- RECENT DEVELOPMENTS

6.1 Nov 13, 2019: electroCore announces third quarter 2019 financial results
6.2 Oct 30, 2019: LivaNova reports third quarter 2019 results
6.3 Oct 29, 2019: SetPoint Medical announces oral presentation of results from U.S. pilot study in rheumatoid arthritis patients at American College of Rheumatology (ACR) Annual Meeting 2019
6.4 Oct 23, 2019: Study published in Neurology shows chronic epilepsy associated with marker of cardiac electrical instability
6.5 Oct 23, 2019: Boston Scientific announces results for third quarter 2019

7 APPENDIX

7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

LIST OF TABLES

Table 1: Vagus Nerve Stimulators (VNS) - Pipeline Products by Stage of Development
Table 2: Vagus Nerve Stimulators (VNS) - Pipeline Products by Territory
Table 3: Vagus Nerve Stimulators (VNS) - Pipeline Products by Regulatory Path
Table 4: Vagus Nerve Stimulators (VNS) - Pipeline Products by Estimated Approval Date
Table 5: Vagus Nerve Stimulators (VNS) - Ongoing Clinical Trials
Table 6: Vagus Nerve Stimulators (VNS) Companies - Pipeline Products by Stage of Development
Table 7: Vagus Nerve Stimulators (VNS) - Pipeline Products by Stage of Development
Table 8: Aucta Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: DECIMA Device - Product Status
Table 10: DECIMA Device - Product Description
Table 11: Aucta Technologies Inc - Ongoing Clinical Trials Overview
Table 12: DECIMA Device - This is a Single-site, Double-blind, Randomized, Prospective, Sham-controlled, Crossover Early Feasibility Study to Determine Whether Ultrasound Vagus Nerve Stimulation (uVNS) Inhibits Postprandial Hyperglycemia in Humans
Table 13: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 14: AMT System - Product Status
Table 15: AMT System - Product Description
Table 16: Vagus Nerve Stimulation (VNS) System - Product Status
Table 17: Vagus Nerve Stimulation (VNS) System - Product Description
Table 18: Boston Scientific Corp - Ongoing Clinical Trials Overview
Table 19: Vagus Nerve Stimulation (VNS) System - Neural Cardiac Therapy for Heart Failure Study
Table 20: Cala Health Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Wearable Neuromodulation Device - Product Status
Table 22: Wearable Neuromodulation Device - Product Description
Table 23: CerboMed GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 24: t-VNS - Dementia - Product Status
Table 25: t-VNS - Dementia - Product Description
Table 26: Cyberonics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Nerve Wrap - Product Status
Table 28: Nerve Wrap - Product Description
Table 29: DuoCure Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Intraluminal Implantable Device - Product Status
Table 31: Intraluminal Implantable Device - Product Description
Table 32: ElectroCore Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 33: GammaCore - Gastroenterology - Product Status
Table 34: GammaCore - Gastroenterology - Product Description
Table 35: gammaCore - Migraine Prevention - Product Status
Table 36: gammaCore - Migraine Prevention - Product Description
Table 37: GammaCore - Neurology - Product Status
Table 38: GammaCore - Neurology - Product Description
Table 39: GammaCore - Post-Traumatic Headache - Product Status
Table 40: GammaCore - Post-Traumatic Headache - Product Description
Table 41: GammaCore - Rheumatoid Arthritis - Product Status
Table 42: GammaCore - Rheumatoid Arthritis - Product Description
Table 43: GammaCore - Sjogren’s Syndrome - Product Status
Table 44: GammaCore - Sjogren’s Syndrome - Product Description
Table 45: Resolve Stimulator - Product Status
Table 46: Resolve Stimulator - Product Description
Table 47: LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
Table 48: Aspire NP - Product Status
Table 49: Aspire NP - Product Description
Table 50: Centro Generator - Product Status
Table 51: Centro Generator - Product Description
Table 52: CentroSR Generator - Product Status
Table 53: CentroSR Generator - Product Description
Table 54: Equilia - Product Status
Table 55: Equilia - Product Description
Table 56: Griffin - Pulse Generator - Product Status
Table 57: Griffin - Pulse Generator - Product Description
Table 58: Intense Neuromodulation System - Heart Failure - Product Status
Table 59: Intense Neuromodulation System - Heart Failure - Product Description
Table 60: Microburst VNS Stimulator - Product Status
Table 61: Microburst VNS Stimulator - Product Description
Table 62: PhoenixRF SR - Product Status
Table 63: PhoenixRF SR - Product Description
Table 64: VITARIA System - Chronic Heart Failure - Product Status
Table 65: VITARIA System - Chronic Heart Failure - Product Description
Table 66: LivaNova PLC - Ongoing Clinical Trials Overview
Table 67: VITARIA System - Chronic Heart Failure - Autonomic Regulation Therapy to Enhance Myocardial Function and Reduce Progression of Heart Failure with Reduced Ejection Fraction
Table 68: Microburst VNS Stimulator - Microburst VNS Therapy Feasibility Study in Subjects with Refractory Epilepsy
Table 69: Medical University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview
Table 70: Transcutaneous Auricular Vagus Nerve Stimulator (taVNS) - Product Status
Table 71: Transcutaneous Auricular Vagus Nerve Stimulator (taVNS) - Product Description

LIST OF FIGURES

Figure 1: Vagus Nerve Stimulators (VNS) - Pipeline Products by Stage of Development
Figure 2: Vagus Nerve Stimulators (VNS) - Pipeline Products by Territory
Figure 3: Vagus Nerve Stimulators (VNS) - Pipeline Products by Regulatory Path
Figure 4: Vagus Nerve Stimulators (VNS) - Pipeline Products by Estimated Approval Date
Figure 5: Vagus Nerve Stimulators (VNS) - Ongoing Clinical Trials

COMPANIES MENTIONED

Aucta Technologies Inc
Boston Scientific Corp
Cala Health Inc
CerboMed GmbH
Cyberonics Inc
DuoCure Ltd.
ElectroCore Inc
LivaNova PLC
Medical University of South Carolina
MicroTransponder Inc
Nexeon MedSystems Inc
Otto Bock HealthCare GmbH
Parasym Ltd
Pulsus Medical LLC (Inactive)
Purdue University
Setpoint Medical Inc
Synergia Medical
SzeleSTIM GmbH
The Feinstein Institute for Medical Research
Trifectas Medical Corp.
University of Pittsburgh
University of Wisconsin Madison


More Publications